中华全科医师杂志
中華全科醫師雜誌
중화전과의사잡지
CHINESE JOURNAL OF GENERAL PRACTITIONERS
2013年
4期
290-291
,共2页
苏永辉%侯冰宗%卜巨源%李霄凌%贾英斌
囌永輝%侯冰宗%蔔巨源%李霄凌%賈英斌
소영휘%후빙종%복거원%리소릉%가영빈
肛门疾病%亚甲蓝
肛門疾病%亞甲藍
항문질병%아갑람
Anus diseases%Methylene blue
将2011年1至12月因肛肠疾病而行手术治疗的患者86例,随机双盲分为两组,各43例,分别行罗哌卡因联合亚甲蓝(观察组)和常规止痛措施处理(对照组).手术后第6 ~ 48小时,疼痛视觉模拟评分法(VAS)评分观察组低于对照组(均P<0.05),术后第72小时评分差异无统计学意义(P>0.05);观察组术后并发症总例数8例(19%)、住院(5.3±2.2)d,低于对照组的15例(35%)和(6.4±1.7)d(均P<0.05).罗哌卡因联合亚甲蓝术中注射可有效缓解肛肠手术患者术后疼痛,减少住院天数及并发症发生.
將2011年1至12月因肛腸疾病而行手術治療的患者86例,隨機雙盲分為兩組,各43例,分彆行囉哌卡因聯閤亞甲藍(觀察組)和常規止痛措施處理(對照組).手術後第6 ~ 48小時,疼痛視覺模擬評分法(VAS)評分觀察組低于對照組(均P<0.05),術後第72小時評分差異無統計學意義(P>0.05);觀察組術後併髮癥總例數8例(19%)、住院(5.3±2.2)d,低于對照組的15例(35%)和(6.4±1.7)d(均P<0.05).囉哌卡因聯閤亞甲藍術中註射可有效緩解肛腸手術患者術後疼痛,減少住院天數及併髮癥髮生.
장2011년1지12월인항장질병이행수술치료적환자86례,수궤쌍맹분위량조,각43례,분별행라고잡인연합아갑람(관찰조)화상규지통조시처리(대조조).수술후제6 ~ 48소시,동통시각모의평분법(VAS)평분관찰조저우대조조(균P<0.05),술후제72소시평분차이무통계학의의(P>0.05);관찰조술후병발증총례수8례(19%)、주원(5.3±2.2)d,저우대조조적15례(35%)화(6.4±1.7)d(균P<0.05).라고잡인연합아갑람술중주사가유효완해항장수술환자술후동통,감소주원천수급병발증발생.
Between January 2011 and December 2011,86 patients undergoing operation for anorectal disease were randomized in a double-blind manner to receive a mixed injection of methylene blue,ropivacaine and sodium chloride (observation group,n =43) or traditional analgesic methods (control group,n =43).Patients in observation group had less visual analog scale (VAS) scores of pain at 6-48 h postoperation than control group (P <0.05).The scores had no significant difference at 72 h postoperation between two groups (P > 0.05).The total postoperative complications (8,19%) and hospitalization duration [(5.3 ± 2.2) days] in observation group were significantly less than those [15,35 % and (6.4 ±1.7) days] in control group (P < 0.05).A mixed injection of methylene blue and ropivacaine intraoperatively can relieve the postoperative pain of patients with anorectal disease and reduce the incidence of postoperative complications and the duration of hospitalization.